Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Testing effectiveness (Phase 2)Ended earlyNCT01050764
What this trial is testing

Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells

Who this might be right for
Leukemia, AcuteChronic Myelogenous Leukemia (CML)Myelodysplastic Syndrome (MDS)+4 more
Everett Meyer 10
Early research (Phase 1)Ended earlyNCT01551043
What this trial is testing

Allo CART-19 Protocol

Who this might be right for
Acute Lymphocytic Leukemia
University of Pennsylvania 2
Early research (Phase 1)Ended earlyNCT05350163
What this trial is testing

T-cell Receptor α/β Depleted Donor Lymphocyte Infusion

Who this might be right for
Lymphoid Leukemia, AcuteMyeloid MalignancyPlasma Cell Tumor
Guenther Koehne 11
Testing effectiveness (Phase 2)UnknownNCT05969743
What this trial is testing

Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease

Who this might be right for
Graft-versus-host-diseaseCMV
Rabin Medical Center 42
Not applicableUnknownNCT05727917
What this trial is testing

Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematological DiseaseAllogeneic Hematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 78
Testing effectiveness (Phase 2)Study completedNCT00004135
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
University of Chicago 19
Not applicableUnknownNCT05156554
What this trial is testing

PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Lymphoma
Sun Yat-sen University 80
Not applicableEnrolling By InvitationNCT07747194
What this trial is testing

Acupuncture to Prevent Nausea and Vomiting After Stem Cell Transplant

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)Hematopoietic Stem Cell Transplantation (HSCT)
Xiao Wang 80
Testing effectiveness (Phase 2)Ended earlyNCT04118556
What this trial is testing

Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT

Who this might be right for
GVHD, Acute
Mats Remberger 12
Testing effectiveness (Phase 2)WithdrawnNCT02715505
What this trial is testing

Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)

Who this might be right for
Inherited Metabolic Disorders IMD
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Looking for participantsNCT06705062
What this trial is testing

Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Cell TransplantGraft Versus Host Disease
Shanghai Jiao Tong University School of Medicine 316
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07471503
What this trial is testing

Gecacitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis

Who this might be right for
Myelofibrosis (MF)HSCT
Institute of Hematology & Blood Diseases Hospital, China 39
Early research (Phase 1)Looking for participantsNCT06575296
What this trial is testing

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

Who this might be right for
Acute LeukemiaAcute Leukemia of Ambiguous LineageAcute Lymphoblastic Leukemia+5 more
City of Hope Medical Center 27
Testing effectiveness (Phase 2)Looking for participantsNCT03509961
What this trial is testing

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Pediatric Transplantation & Cellular Therapy Consortium 95
Testing effectiveness (Phase 2)Ended earlyNCT00005987
What this trial is testing

Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Masonic Cancer Center, University of Minnesota 87
Early research (Phase 1)Active Not RecruitingNCT03613532
What this trial is testing

Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)+2 more
Jacqueline Garcia, MD 102
Large-scale testing (Phase 3)Study completedNCT00382109
What this trial is testing

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Who this might be right for
B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionGraft Versus Host Disease+3 more
Children's Oncology Group 146
Testing effectiveness (Phase 2)Ended earlyNCT05447663
What this trial is testing

Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Stem Cell Transplantation
Novartis Pharmaceuticals 8
Early research (Phase 1)Study completedNCT01445132
What this trial is testing

Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation

Who this might be right for
Chronic Lymphocytic Leukemia
National Cancer Institute (NCI) 11
Next Page